Head & Neck/Thyroid Cancers
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Clinical Insights
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
From the Journals
Hair dye and cancer study ‘offers some reassurance’
Conference Coverage
VTE, sepsis risk increased among COVID-19 patients with cancer
Cancer patients had significantly lower hemoglobin levels, platelet counts, and red and white blood cell counts.
Guidelines
First guideline on NGS testing in cancer, from ESMO
From the Journals
Immunotherapy should not be withheld because of sex, age, or PS
From the Journals
Aspirin may accelerate cancer progression in older adults
From the Journals
Age, smoking among leading cancer risk factors for SLE patients
While older age was a risk factor for both breast and nonmelanoma skin cancers, use of antimalarial drugs lowered the risk of both.
From the Journals
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
Clinical Insights
Artificial intelligence matches cancer genotypes to patient phenotypes
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...